1. Pharmacological or genetic orexin1 receptor inhibition attenuates MK-801 induced glutamate release in mouse cortex;Aluisio;Front. Neurosci.,2014
2. Alvaro, G., Amantini, D., Castiglioni, E., Di Fibio, R., Pavone, F., 2010. (WO2010063663) N-{[(IR,4S,6R-3-(2-pyridinylcarbonyl)-3-azabicyclo [4.1.0]hept-4-YL] methyl}-2-heteroarylamine derivatives and uses thereof. WO 2010/063663.
3. Alvaro, G., Amantini, D., Stasi, L.P., 2009. Pyridine derivatives used to treat orexin related disorders. WO 2009124956.
4. Orexin-1 and orexin-2 receptor antagonists reduce ethanol self-administration in high-drinking rodent models;Anderson;Front. Neurosci.,2014
5. Orexin receptor antagonists: historical perspectives and future opportunities;Andrews;Curr. Top. Med. Chem.,2016